OTCMKTS:MSLP MusclePharm (MSLP) Stock Price, News & Analysis → Elon Musk’s Final Masterpiece: “X-9840” (From Paradigm Press) (Ad) Free MSLP Stock Alerts $0.0002 0.00 (0.00%) (As of 12/16/2022) Add Compare Share Share Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.0002▼$0.0002Volume1,000 shsAverage Volume26,442 shsMarket Capitalization$6,678.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get MusclePharm alerts: Email Address Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution About MusclePharm Stock (OTCMKTS:MSLP)MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.Read More MSLP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MSLP Stock News HeadlinesFebruary 24, 2024 | forbes.comBest Protein Powder For Muscle Gain, According To ExpertsFebruary 11, 2024 | businessinsider.comThe 5 best muscle rubs of 2024November 2, 2023 | msn.com7 Healthy Habits to Decrease the Risk of Breast CancerOctober 2, 2023 | msn.comFitLife Brands swoops in for bankrupt MusclePharm assetsSeptember 28, 2023 | msn.comUS Bankruptcy Court Approves FitLife's $18.5M Acquisition Of MusclePharmSeptember 27, 2023 | benzinga.comFitLife Brands to Acquire Substantially All of the Assets of MusclePharm CorporationJuly 9, 2023 | health.usnews.comWhat Are the Best Foods for Building Muscle?April 6, 2023 | forbes.comHow To Build Muscle, According To ExpertsMarch 20, 2023 | health.usnews.com11 Benefits of Strength Training That Have Nothing to Do With Muscle SizeMarch 7, 2023 | health.usnews.comCan You Gain Muscle While Losing Weight?February 16, 2023 | foxnews.comElectric Dodge muscle car spotted in 'Fast X' trailerFebruary 11, 2023 | uk.investing.comDae Hwa Pharm Co Ltd (067080)December 23, 2022 | thestreet.comWhy MusclePharm (MSLP) Stock Is Up TodayJuly 6, 2022 | finance.yahoo.comMusclePharm Announces the Launch of FitMiss EnergyJune 23, 2022 | seekingalpha.comMusclePharm Files For Uplisting IPO To NasdaqJune 7, 2022 | seekingalpha.comMusclePharm announces additional private placement of $2.5M senior secured notesMay 24, 2022 | finance.yahoo.comMusclePharm to Present at the LD Micro Invitational XII ConferenceMay 16, 2022 | benzinga.comMusclePharm Announces First Quarter 2022...May 16, 2022 | seekingalpha.comMusclePharm Corporation (MSLP) CEO Ryan Drexler on Q1 2022 Results - Earnings Call TranscriptMay 16, 2022 | finance.yahoo.comMusclePharm Announces First Quarter 2022 Financial ResultsMay 5, 2022 | morningstar.comCorrection: MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial ResultsApril 14, 2022 | finance.yahoo.comMusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial ResultsApril 12, 2022 | finance.yahoo.comMusclePharm to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, April 14, 2022March 31, 2022 | finance.yahoo.comMusclePharm Announces Launch into Ready-to-Drink Protein CategoryMarch 11, 2022 | seekingalpha.comMusclePharm releases preliminary Q421 resultsSee More Headlines Receive MSLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/10/2015Today6/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Staples Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:MSLP CUSIPN/A CIK1415684 Webwww.musclepharm.com Phone(800) 292-3909FaxN/AEmployees27Year Founded2008Profitability EPS (Most Recent Fiscal Year)($0.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,870,000.00 Net Margins-38.51% Pretax Margin-38.52% Return on EquityN/A Return on Assets-169.56% Debt Debt-to-Equity RatioN/A Current Ratio0.25 Quick Ratio0.23 Sales & Book Value Annual Sales$50.04 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.94) per share Price / Book0.00Miscellaneous Outstanding Shares33,390,000Free Float13,121,000Market Cap$6,678.00 OptionableNot Optionable Beta-0.07 Social Links 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Ryan Charles Drexler (Age 51)Exec. Chairman & CEO Comp: $1.64MJohn Mills MillsSr. Managing DirectorMr. Gary Charles Shirshac (Age 60)Interim Chief Financial Officer Mr. Eric Chin (Age 42)Chief Accounting Officer & Director Dr. Roscoe M. Moore Jr. (Age 77)DSc, DVM, MPH, Ph.D., Chief Scientific Director & Member of Scientific Advisory Board Mr. Mark E. Groussman (Age 49)Consultant More ExecutivesKey CompetitorsNVN LiquidationNASDAQ:NOVNQBohai Pharmaceuticals GroupOTCMKTS:BOPHEvelo BiosciencesNASDAQ:EVLOParnell PharmaceuticalsOTCMKTS:PARNFScopus BioPharmaNASDAQ:SCPSView All Competitors MSLP Stock Analysis - Frequently Asked Questions How have MSLP shares performed in 2024? MusclePharm's stock was trading at $0.0010 at the beginning of the year. Since then, MSLP shares have decreased by 80.0% and is now trading at $0.0002. View the best growth stocks for 2024 here. How were MusclePharm's earnings last quarter? MusclePharm Co. (OTCMKTS:MSLP) issued its quarterly earnings results on Monday, August, 10th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.32. The company earned $50.48 million during the quarter, compared to analyst estimates of $55 million. What other stocks do shareholders of MusclePharm own? Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DALR), EVRAZ (EVRZF), Rent-A-Center (RCII), AdvanSix (ASIX), Accuray (ARAY), Apollo Global Management (APO), TD Ameritrade (AMTD), Alaska Communications Systems Group (ALSK) and Alnylam Pharmaceuticals (ALNY). How do I buy shares of MusclePharm? Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MSLP) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MusclePharm Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share MusclePharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.